达布拉芬尼通过激活GCN2改变了MDSC的分化和功能
M Teresa Ciudad1,2, Rene Quevedo1,2, Sara Lamorte1,2
1Tumor Immunotherapy Program, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Cancer research communications
|February 29, 2024
概括
达布拉菲尼布是一种BRAF抑制剂,通过激活GCN2激酶,可以减少髓质衍生抑制细胞 (MDSCs). 这影响了MDSC的发展和功能,为癌症治疗提供了新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 向癌症治疗可以以不太了解的方式影响抗瘤免疫反应.
- BRAF抑制剂达布拉费尼布激活了综合应激反应 (ISR) 激酶GCN2.
- ISR信号传递对于髓衍生抑制细胞 (MDSC) 的发育和功能至关重要.
研究的目的:
- 调查达布拉费尼布对MDSC分化和抑制活性的影响.
- 阐明GCN2激活在达布拉费尼布对MDSCs的影响中的作用.
- 为了了解dabrafenib诱导的MDSC中的转录和代谢变化.
主要方法:
- 在体外评估MDSC抑制活性.
- 测量单细胞原体向多态核细胞 (PMN) -MDSCs的转变.
- 利用转录概况来分析MDSCs中的基因表达变化.
- 在用达布拉费尼布治疗的瘤携带小鼠中评估MDSC群体.
主要成果:
- 达布拉芬尼减弱了MDSC介导的T细胞抑制.
- 对PMN-MDSC过渡和增殖停止的单细胞原体的GCN2-依赖性抑制导致PMN-MDSCs减少.
- 达布拉费尼布诱导的GCN2激活改变了MDSC代谢,并抑制了PMN发展途径.
- 在体内研究表明,在接受达布拉费尼布治疗的小鼠中,PMN-MDSCs显著减少.
结论:
- 达布拉芬尼对MDSC群体的系统性影响以及瘤微环境中的影响.
- 达布拉费尼布激活GCN2会破坏MDSC的发育和功能.
- 这些发现揭示了达布拉费尼布的新型脱效应,对癌症治疗和组合策略有影响.
相关概念视频
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K


